Breast cancer, being a disease with very high prevalence in the female population, has permanently attracted the attention of biologists, biochemists, pathologists, surgeons, and oncologists. In the U.S. alone approximately 120,000 new cases are diagnosed and 37,000 deaths a year are recorded as an outcome. Early diagnosis, clear cut prognosis and the hope of new therapeutic approaches has spurred the enthusiasm of researchers, who with the advent of newer methodologies, tried to employ it in different approaches to the breast cancer patient. In spite of the efforts devoted towards the...

Reporting on the clinical procedures that have now been developed from the initial research on using monoclonal antibodies to diagnose and treat breast cancer, the 21 papers also review promising research still in the pipeline. The various descriptions of breast epithelial antigens consider their mo

The 1992 session of the biennial workshop concerned with the immunology of breast cancer focused on the recent advances in understanding the molecular biology both of antigens associated with breast cancer and of their corresponding antibodies. Among the topics of the 19 papers are peptide epitopes

Today, advances in the area of immunology and breast cancer are made at an increasing rate, yielding an amount of information that can become unwieldy. The opportunity for scientists in this area of research to gather together to exchange results and working hypotheses represents, in my belief, a very attractive proposition. With this in mind, these workshops have been convened with two year intervals for the last ten years. In each of them, selected topics have been highlighted. The present workshop underscores the large advancements made in the molecular biology of both breast cancer...